152 related articles for article (PubMed ID: 16382710)
1. New treatment approaches in multiple myeloma.
Berrebi A
Isr Med Assoc J; 2005 Dec; 7(12):820-1. PubMed ID: 16382710
[No Abstract] [Full Text] [Related]
2. Multiple myeloma.
Kyle RA; Rajkumar SV
N Engl J Med; 2004 Oct; 351(18):1860-73. PubMed ID: 15509819
[No Abstract] [Full Text] [Related]
3. Response to bortezomib is associated to osteoblastic activation in patients with multiple myeloma.
Zangari M; Esseltine D; Lee CK; Barlogie B; Elice F; Burns MJ; Kang SH; Yaccoby S; Najarian K; Richardson P; Sonneveld P; Tricot G
Br J Haematol; 2005 Oct; 131(1):71-3. PubMed ID: 16173965
[TBL] [Abstract][Full Text] [Related]
4. Novel agents in myeloma: an exciting saga.
Mark T; Niesvizky R; Coleman M
Cancer; 2009 Jan; 115(2):236-42. PubMed ID: 19025986
[No Abstract] [Full Text] [Related]
5. New drugs for multiple myeloma.
Anderson KC
Clin Adv Hematol Oncol; 2006 Aug; 4(8):592-4. PubMed ID: 17099617
[No Abstract] [Full Text] [Related]
6. Proteasome inhibitor holds promise for patients with refractory multiple myeloma.
Expert Rev Anticancer Ther; 2001 Dec; 1(4):509-10. PubMed ID: 12113081
[No Abstract] [Full Text] [Related]
7. Perspective on the current use of bortezomib in multiple myeloma.
San-Miguel J; Bladé J
Haematologica; 2006 Jul; 91(7):871-2. PubMed ID: 16818272
[No Abstract] [Full Text] [Related]
8. [Multiple myeloma -- therapy].
Jung W; Zettl F; Schroers R
Dtsch Med Wochenschr; 2005 Feb; 130(6):283-6; quiz 287-90. PubMed ID: 15692903
[No Abstract] [Full Text] [Related]
9. New agents and approaches in the treatment of multiple myeloma.
Anderson KC
Clin Adv Hematol Oncol; 2003 Mar; 1(3):151-2. PubMed ID: 16224394
[No Abstract] [Full Text] [Related]
10. [Proteasome inhibitors for multiple myeloma].
Yano H; Iida S
Nihon Rinsho; 2007 Jan; 65 Suppl 1():601-4. PubMed ID: 17476759
[No Abstract] [Full Text] [Related]
11. Multiple myeloma.
Raab MS; Podar K; Breitkreutz I; Richardson PG; Anderson KC
Lancet; 2009 Jul; 374(9686):324-39. PubMed ID: 19541364
[TBL] [Abstract][Full Text] [Related]
12. Bortezomib, thalidomide, and dexamethasone for relapsed multiple myeloma: add it up and wait.
Badros A; Gahres N
Clin Adv Hematol Oncol; 2005 Dec; 3(12):916-7; discussion 918. PubMed ID: 16555432
[No Abstract] [Full Text] [Related]
13. Bortezomib in multiple myeloma.
Faix JD
N Engl J Med; 2003 Sep; 349(13):1287-8; author reply 1287-8. PubMed ID: 14507954
[No Abstract] [Full Text] [Related]
14. Bortezomib in multiple myeloma.
Meisler AI
N Engl J Med; 2003 Sep; 349(13):1287-8; author reply 1287-8. PubMed ID: 14510013
[No Abstract] [Full Text] [Related]
15. [Thalidomide treatment in multiple myeloma].
Hattori Y
Rinsho Ketsueki; 2003 May; 44(5):302-12. PubMed ID: 12822404
[No Abstract] [Full Text] [Related]
16. Proteasome inhibition for treatment of multiple myeloma: clinical update.
Stadtmauer EA
J Natl Compr Canc Netw; 2004 Nov; 2 Suppl 4():S10-5. PubMed ID: 19795531
[TBL] [Abstract][Full Text] [Related]
17. [Treatment of myeloma when high dose therapy is not possible. New drugs--alternatives for elderly patients].
Mellstedt H; Gimsing P; Waage A
Lakartidningen; 2011 Oct 19-25; 108(42):2090-4. PubMed ID: 22165535
[No Abstract] [Full Text] [Related]
18. New therapies for the treatment of multiple myeloma.
Richardson P
Clin Adv Hematol Oncol; 2005 May; 3(5):345-6. PubMed ID: 16167007
[No Abstract] [Full Text] [Related]
19. Current status of new drugs for the treatment of patients with multiple myeloma.
Kenealy M; Prince HM
Intern Med J; 2006 Dec; 36(12):781-9. PubMed ID: 17096741
[TBL] [Abstract][Full Text] [Related]
20. New drugs for myeloma.
Richardson PG; Mitsiades C; Schlossman R; Munshi N; Anderson K
Oncologist; 2007 Jun; 12(6):664-89. PubMed ID: 17602058
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
